BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 10, 2010
View Archived Issues
New Pim kinase inhibitor ARRY-770 reduces airway hyperresponsiveness in mice
Read More
Adalimumab improves quality of life in Crohn's disease patients
Read More
Evotec Neurosciences claims bradykinin B1 receptor antagonists
Read More
CETP gene polymorphism linked to reduced risk for dementia
Read More
Topical WBI-1001 improves atopic dermatitis in double-blind trial
Read More
Roche discovers new GlyT-1 inhibitors
Read More
Merck KGaA discloses novel tyrosine kinase inhibitors
Read More
Bayer Schering claims new adenosine A1 receptor antagonists
Read More
Sanofi-aventis patents new cannabinoid CB1 receptor antagonists
Read More
NIAID awards PDS phase II grant for HPV cancer vaccine
Read More
Ark withdraws Cerepro MAA after EMA's request for further trial in malignant glioma
Read More
Vernalis terminates agreement with PCH and regains rights to frovatriptan
Read More
Biotie and Pfizer to end discovery phase of development of PDE10 inhibitors for schizophrenia
Read More
Stanford University requests data from Favrille's cancer vaccine trials
Read More
Ischemix begins phase IIa CMX-2043 trial in ischemia reperfusion injury
Read More
Ista receives action date for FDA review of XiDay sNDA
Read More
Chimerix begins phase II CMX-001 study in CMV-seropositive stem cell transplant recipients
Read More
Bristol-Myers and AstraZeneca begin phase IV Onglyza trial
Read More
Enrollment begins in phase IIb trial of NTx-265 in acute ischemic stroke
Read More
mtm laboratories launches cervical cancer test CINtec Plus in Europe
Read More
Omthera to advance Epanova for hypertriglyceridemia
Read More
Celltrion develops broad-spectrum human monoclonal antibodies against influenza
Read More
Omeros licenses Asubio's PDE7 inhibitors for movement disorders
Read More
Harvard and Dana-Farber grant Acetylon exclusive license to HDAC inhibitor discovery platform
Read More
Abbott and GSK to develop molecular diagnostic test for skin cancer treatment
Read More